During the corresponding time, Steris Plc recorded a revenue increase by 7.28 % year on year, sequentially revenue grew by 6.16 %. While revenue at the Steris Plc's corporate clients
Steris Plc's Comment on Sales, Marketing and Customers
The company provides products and services to healthcare, medical device, and pharmaceutical customers worldwide. Its offerings include consumable products such as detergents, endoscopy accessories, barrier products, instruments, and tools; services including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair, laboratory testing, and outsourced reprocessing; capital equipment like sterilizers, surgical tables, and automated endoscope reprocessors; and connectivity solutions such as operating room integration. The company operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment serves sterile processing departments and procedural centers, including operating rooms and endoscopy suites, by providing infection prevention consumables, capital equipment, equipment maintenance services, repair of reusable procedural instruments, and outsourced instrument reprocessing services. Market growth is influenced by factors such as aging populations, advancements in healthcare delivery, new technologies, government policies, economic conditions, increased demand for medical procedures including preventive screenings like endoscopies and colonoscopies, and customers' focus on operational efficiency.
Steris Plc’s Comment on Sales, Marketing and Customers
The company provides products and services to healthcare, medical device, and pharmaceutical customers worldwide. Its offerings include consumable products such as detergents, endoscopy accessories, barrier products, instruments, and tools; services including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair, laboratory testing, and outsourced reprocessing; capital equipment like sterilizers, surgical tables, and automated endoscope reprocessors; and connectivity solutions such as operating room integration. The company operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment serves sterile processing departments and procedural centers, including operating rooms and endoscopy suites, by providing infection prevention consumables, capital equipment, equipment maintenance services, repair of reusable procedural instruments, and outsourced instrument reprocessing services. Market growth is influenced by factors such as aging populations, advancements in healthcare delivery, new technologies, government policies, economic conditions, increased demand for medical procedures including preventive screenings like endoscopies and colonoscopies, and customers' focus on operational efficiency.
Sources:
Steris Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Steris Plc’s corporate clients.
For your research, we’ve provided 9 tables on Steris Plc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
71.1 %